Ofloxacin-BSA
Ofloxacin-BSA is a conjugate of Ofloxacin and BS. By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells[1].
Product Specifications
UNSPSC
12352100
Target
Biochemical Assay Reagents
Related Pathways
Others
Field of Research
Inflammation/Immunology
Smiles
[Ofloxacin-BSA]
References & Citations
[1]Todd PA, et al. Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use. Drugs. 1991 Nov;42 (5) :825-76.
Shipping Conditions
Room temperature
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880012-500 1x 500 µL
Tyrosinase (T311), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC811224-500 1x 500 µL
HCG-beta (HCGb/54+ HCGb/459), CF680R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401098-100 1x 100 µL
Cyclin B1 (CCNB1/1098), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472007-500 1x 500 µL
MHC II, Mouse (MK-D6), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 